Chlamydomonas allensworthii
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Chlamydomonas allensworthii |
|---|---|
| Database Name | cmaup_plants |
| Synonyms | Chlamydomonas Allensworthii |
| Ipni Id | U02133-1 |
| Plant Name | Chlamydomonas Allensworthii |
| Genus Tax Id | 3052 |
| Disease Name | Multiple myeloma, Glaucoma, Diabetes mellitus, type unspecified, Pancreatic cancer, Endometrial cancer, Solid tumour/cancer, Myocardial infarction, Melanoma, Metastatic malignant neoplasm, Ischaemic/haemorrhagic stroke, Irritable bowel syndrome, Pleomorphic sarcoma, Breast cancer, Stomach cancer, Skin tag/polyp, Synthesis disorder, Pain, unspecified, Acquired hypomelanotic disorder, Herpes simplex infection, Choreiform disorder, Lung cancer, Alzheimer disease, Myelodysplastic syndrome, Atopic eczema, Cervical cancer, Peritoneal cancer, Acute diabete complication, Motor neuron disease, Chronic pain, Neuropathy, Type 2 diabetes mellitus, Diabetic foot ulcer, Metastatic lymph node neoplasm, Renal cell carcinoma, Myeloproliferative neoplasm, Intracerebral haemorrhage, Colorectal cancer, Fungal infection, Mature T-cell lymphoma, Indeterminate colitis, Coronary thrombosis, Unspecific substance harmful effect, Acute myeloid leukaemia, Pediculosis, Mature B-cell lymphoma, Chronic arterial occlusive disease, Non-small cell lung cancer, Prostate cancer, Osteosarcoma, Rheumatoid arthritis, Lysosomal disease, Liver cancer, Metastatic biliary tract neoplasms, Asthma, Unspecific body region injury, Pituitary gland disorder, Mood disorder, Ischemia, Psoriasis, Thrombosis, Brain cancer, Malignant mesenchymal neoplasm, Multiple sclerosis, Synovial sarcoma, Ovarian cancer, Thyroid cancer, Epidermal dysplasias, Cataract, Leiomyosarcoma, Malignant digestive organ neoplasm, Head and neck cancer, Psychotic disorder, Myasthenia gravis, Idiopathic interstitial pneumonitis, Thyrotoxicosis, Nutritional deficiency, Mature B-cell leukaemia, Cardiovascular disease, Chronic kidney disease, Gastrointestinal stromal tumour, Muscular dystrophy, Parkinsonism, Substance abuse, Coagulation defect, Autoimmune disease, Spinal cord/cranial nerve neoplasm, BCR-ABL1-negative chronic myeloid leukaemia, Skin postprocedural disorder, Testicular cancer, Biliary tract cancer, Ischemic heart disease, Peroxisomal disease, Malignant haematopoietic neoplasm, Fallopian tube cancer, Thrombocytopenia, Retinopathy, Depression, Angina pectoris, Bleeding disorder, Extraocular muscle disorder, Parasitic worm infestation, Hypopharyngeal cancer, Acute/subacute hepatic failure, Urethral cancer, Coronavirus infection, Mild neurocognitive disorder, Oesophageal/gastroduodenal disorder, Type-1/2 diabete, Postoperative inflammation, Dementia, Metastatic digestive system neoplasm, Crohn disease, Lupus erythematosus, Schizophrenia, General pain disorder, Female pelvic pain, Hyper-lipoproteinaemia, Hepatitis virus infection, Multiple structural anomalies syndrome, Cerebral ischaemic stroke, Ocular cancer, Nasopharyngeal cancer, Colon cancer, Liver disease, Skin and skin-structure infection, Digestive organ benign neoplasm, Primary sclerosing cholangitis, Neoplasms, Dysplastic naevus, Obesity, Metabolic disorder, Follicular lymphoma, Carcinosarcoma of uterus, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Zika virus disease, Dengue fever, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Leishmaniasis, Adenocarcinoma of stomach, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Diffuse large B-cell lymphomas, Myotonic dystrophy, Other specified malignant neoplasms of kidney, except renal pelvis, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Tetralogy of Fallot, Other specified malignant neoplasms ofcolon, Melanoma of skin, Hepatocellular carcinoma of liver, Other specified malignant neoplasms of bronchus or lung, Superficial ovarian endometriosis, Malignant neoplasms of oesophagus, Urothelial carcinoma of bladder, Cytomegaloviral disease, Adenocarcinoma of prostate, Systemic lupus erythematosus, Malignant neoplasms of thyroid gland, unspecified, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Chikungunya virus disease, Polycystic ovary syndrome, Malignant neoplasms of thymus, Invasive carcinoma of breast, Human immunodeficiency virus disease without mention of tuberculosis or malaria, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Germ cell tumour of testis, Carpal tunnel syndrome, Ebola virus disease, Malignant neoplasms of adrenal gland, Lyme borreliosis, Gliomas of brain |
| Species Name | Chlamydomonas allensworthii |
| Genus Name | Chlamydomonas |
| Species Tax Id | 51691 |
| Disease Id | 2A83, 9C61, 5A14, 2C10, 2C76, 2A00-2F9Z, BA41-BA43, 2C30, 2D50-2E09, 8B20, DD91, 2B54, 2C60-2C6Y, 2B72, EK71, 5C52-5C59, MG3Z, ED63, 1F00, 8A01, 2C25, 8A20, 2A37, EA80, 2C77, 2C51, 5A2Y, 8B60, MG30, 8C0Z, 5A11, BD54, 2D60, 2C90, 2A20, 8B00, 2B91, 1F29-1F2F, 2A90, DD72, BA43, NE6Z, 2A60, 1G00, 2A85, BD4Z, 2C82, 2B51, FA20, 5C56, 2C12, 2C14-2C17, CA23, ND56, 5A60-5A61, 6A60-6E23, 8B10-8B11, EA90, DB61-GB90, 2A00, 2B5D-2B5Y, 8A40, 2B5A, 2C73, 2D10, EK90, 9B10, 2B58, 2C11, 2D42, 6A20-6A25, 8C6Y, CB03, 5A02, 5B50-5B71, 2A82, BA00-BE2Z, GB61, 2B5B, 8C70, 8A00, 6C40, 3B10, 4A40-4A45, 2A02, 2A41, EL8Y, 2C80, 2C17, BA40-BA6Z, 5C57, 2B33, 2C74, 3B64, 9B71, 6A70-6A7Z, BA40, GA20-GA21, 9C82, 1F90, 2B6D, DB91, 2C93, 1D92, 6D71, DD90, 5A10-5A11, 1A00-CA43, 6D80-6D8Z, 2D8Y, DD70, 4A40, 6A20, 8.00E+43, GA34, 5C80, 1E50-1E51, LD2F, 8B11, 2D00-2D07, 2B6B, 2B90, DB90-DB9Z, 1F28-1G0Z, 2.00E+92, DB96.2, 2, XH9035, 5B80-5B81, 5C50-5D2Z, 2A80, 2C76.43, 2C73.4, XH3854, 1D48, 1D2Z, 2C15, 2C12.01, 1F54, 2B72.0, 2D60.0, 2A81, 8C71.0, 2C90.Y, 2C25.2, 1D46, 2C10.0, 2C26.0, LA88.2, 2B90.Y, 2C12.02, 2C25.Y, GA10.B4, 2B70, 2C94.2, 1D82, 2C82.0, 4A40.0, 2D10.Z, 2C25.0, 2C76.Z, 1D40, 5A80.1, 2C27, 2C61, 1C62, 2A00.00, XH6153, 2C80.2, 8C10.0, 1D60.01, 2D11, 1C1G, 2A00.0 |
| Family Name | Chlamydomonadaceae |
| Family Tax Id | 3051 |
- 1. (1r,2s,4r)-2-Hydroxy-Alpha,alpha,4-Trimethylcyclohexanemethanol (PubChem CID: 9920491)
- 2. (1r,4s,4ar,7s,8ar)-1,6-Dimethyl-4-Propan-2-Yl-3,4,4a,7,8,8a-Hexahydro-2h-Naphthalene-1,7-Diol (PubChem CID: 12304867)
- 3. (1s,2s,20s,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37,46-Hexadecahydroxy-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 154497663)
- 4. (2r)-2-Hydroxypentanedioic Acid (PubChem CID: 439391)
- 5. (2r,3r)-3,4'-Dihydroxy-5,7-Dimethoxyflavone (PubChem CID: 10403456)
- 6. (2r,3r)-3,5,7-Trihydroxy-2-(4-Hydroxyphenyl)-6-[(1r)-1-(4-Hydroxyphenyl)ethyl]-2,3-Dihydrochromen-4-One (PubChem CID: 163077411)
- 7. (2r,3r)-3,5-Dihydroxy-2-(4-Hydroxyphenyl)-6-[(1r)-1-(4-Hydroxyphenyl)ethyl]-7-Methoxy-2,3-Dihydrochromen-4-One (PubChem CID: 162946913)
- 8. 1alpha,3beta,4beta-P-Menthane-3,8-Diol (PubChem CID: 22214620)
- 9. 2-Hydroxy-4,4,6,6-Tetramethyl-2-(3-Methylbutyl)-5-[(2r,3s,4r,5s,6s)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxycyclohexane-1,3-Dione (PubChem CID: 163019780)
- 10. 2-Palmitoylglycerol (PubChem CID: 123409)
- 11. 6-Octenal, 3,7-Dimethyl-, (3r)- (PubChem CID: 75427)
- 12. [(1s,3r,6s,7s,8s,11s,12s,15r,16r)-7,12,16-Trimethyl-15-[(2r)-6-Methyl-5-Methylideneheptan-2-Yl]-6-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] (Z)-11-[(2r,3r)-3-Pentyloxiran-2-Yl]undec-9-Enoate (PubChem CID: 162872523)
- 13. Alpha-D-Glucose 1-Phosphate (PubChem CID: 65533)
- 14. Alpha-Tocopherol (PubChem CID: 14985)
- 15. Aromadendrin (PubChem CID: 122850)
- 16. Aromadendrin 7-Methyl Ether (PubChem CID: 181132)
- 17. Beta-Citronellol, (R)- (PubChem CID: 101977)
- 18. Beta-Citronellol, (S)- (PubChem CID: 7793)
- 19. Beta-Sitosterol (PubChem CID: 222284)
- 20. Betulinic Acid (PubChem CID: 64971)
- 21. Betulonic Acid (PubChem CID: 122844)
- 22. Cadin-4-En-10-Ol (PubChem CID: 10398656)
- 23. Cholesterol (PubChem CID: 5997)
- 24. Citramalic Acid (PubChem CID: 1081)
- 25. Cycloeucalenol (PubChem CID: 101690)
- 26. D-(-)-Fructose (PubChem CID: 5984)
- 27. D-Galactose (PubChem CID: 6036)
- 28. D-Glucuronic Acid (PubChem CID: 94715)
- 29. Daucosterin Acetate (PubChem CID: 12895763)
- 30. Ellagic Acid (PubChem CID: 5281855)
- 31. Erythrodiol (PubChem CID: 101761)
- 32. Eucalyptin (PubChem CID: 76573)
- 33. Fustin (PubChem CID: 5317435)
- 34. Gadoleic Acid (PubChem CID: 5282767)
- 35. Garbanzol (PubChem CID: 442410)
- 36. Heptadecanoic Acid (PubChem CID: 10465)
- 37. Isopulegol (PubChem CID: 170833)
- 38. Ketoleucine (PubChem CID: 70)
- 39. Linoleic Acid (PubChem CID: 5280450)
- 40. Menthoglycol (PubChem CID: 19100)
- 41. Morolic Acid (PubChem CID: 489944)
- 42. N-Acetylserine (PubChem CID: 65249)
- 43. Neoruscogenin (PubChem CID: 9910474)
- 44. Palmitic Acid (PubChem CID: 985)
- 45. Pentadecanoic Acid (PubChem CID: 13849)
- 46. Putrescine (PubChem CID: 1045)
- 47. Quinate (PubChem CID: 6508)
- 48. Rhamnocitrin (PubChem CID: 5320946)
- 49. Ruscogenin (PubChem CID: 441893)
- 50. Sesamin (PubChem CID: 72307)
- 51. Shikimic Acid (PubChem CID: 8742)
- 52. Sitogluside (PubChem CID: 5742590)
- 53. Sodium 4-Hydroxybenzoate (PubChem CID: 16219477)
- 54. Sodium Benzoate (PubChem CID: 517055)
- 55. Squalene (PubChem CID: 638072)
- 56. Stearic Acid (PubChem CID: 5281)
- 57. Stigmast-4-En-3-One (PubChem CID: 5484202)
- 58. Syringaldehyde (PubChem CID: 8655)
- 59. Syringic Acid (PubChem CID: 10742)
- 60. T-Muurolol (PubChem CID: 3084331)
- 61. Trans-Calamenene (PubChem CID: 6429022)
- 62. Ursolic Acid (PubChem CID: 64945)
- 63. Yangambin (PubChem CID: 443028)
- 1. Alzheimer's Disease 1
- 2. Arthritis, Rheumatoid
- 3. Asthma
- 4. Cardiovascular Diseases
- 5. Cataract
- 6. Cholera
- 7. Crohn Disease
- 8. Dementia
- 9. Diabetes Mellitus
- 10. Diabetes Mellitus, Type 1
- 11. Glaucoma
- 12. Liver Neoplasms
- 13. Lupus Erythematosus, Systemic
- 14. Muscular Dystrophies
- 15. Myocardial Infarction
- 16. Obesity
- 17. Psoriasis
- 18. Psychotic Disorder
- 19. Thrombocytopenia
Not listed in any formulations.